Develops biomedical products from mammali

Orthocell Ltd. engages in the development and commercialization of cell therapies and related technologies. Its products include CelGro which is a naturally derived collagen medical device for soft tissue repair, and Antilogous Tenocyte Implantation (Ortho-ATI) for chronic, treatment resistant tendon injuries. The company was founded by Paul Anderson and Min Hao Zheng on March 21, 2006 and is headquartered in Murdoch, Australia.

Angiotech BioMaterials Corp. develops tissue repair and regeneration technology. The company was founded by David J. Foster in June 1997 and is headquartered in Palo Alto, CA.

Orthovita is a spine and orthopedic biosurgery company that manufactures and markets orthobiologic and biosurgery products. Its orthobiologics platform offers products for the fusion, regeneration, and fixation of human bones; and the biosurgery platform provides products for controlling intra-operative bleeding. Orthovita sells its products directly, as well as through non-stocking distributors and independent sales agents in the United States; and directly and through independent stocking distributors internationally. The company has strategic partnerships with Kensey Nash Corporation, Angiotech Pharmaceuticals, and Medafor. It was founded in 1992 and is based in Malvern, Pennsylvania.

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

Jiangsu Dongfang Yanmei Biotechnology Development Co., Ltd., established on 2021-12-30, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Cosmetic production;pharmaceutical production;Drug retail;Drug Wholesale(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technical extension services;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Cosmetics Wholesale;Cosmetics Retail;Medical Research and Experimental Development;Business Management Consulting(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Aap Biomaterials GmbH develops produces and marketing of bone cements, mixing systems and related accessories specializes. The firm is engaged in the development of innovative bone substitutes and cements. It offers bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty and bone cements and accessories for the application in vertebroplasty and kyphoplasty. The company is headquartered in Dieburg, Germany.

Angiotech Pharmaceuticals (US), Inc. develops drugs for medicinal chemicals and botanical products. The company is located in North Bend, WA.

Zhejiang Chongshan Biological Products Co., Ltd., established on 2015-04-02, Business scope includes licensed projects:Production of protective equipment for medical personnel(Class II medical device);Class III medical device business;Production of Class II Medical Devices;Production of Class III Medical Devices;Internet Information Service for Medical Devices;Production of medical masks;Cosmetic production;Import and export;Food additive production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Sales of Class II Medical Devices;Sales of Class I Medical Devices;Production of Class I Medical Devices;Production of protective equipment for medical personnel(Ι class medical device);Wholesale of protective equipment for medical staff;software development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Medical Mask Retail;Domestic trade agent;Wholesale medical masks;Retailing of protective equipment for healthcare workers;Cosmetics Retail;Cosmetics Wholesale;Sales of hygiene products and single-use medical products;internet sales(Except for products that require a license for sale);Medical Research and Experimental Development;R&D and application of cell technology;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;New material technology research and development;Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Research and development of bio-based materials technology;Sales of bio-based materials;Manufacturing of bio-based materials;Research and development of bio-based material polymerization technology;property management;Non-residential real estate leases;Storage equipment rental service;Medical equipment rental;Office equipment rental service;brand management;Food Additive Sales;Manufacturing of daily chemical products;Sales of daily chemical products(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Collagen Aesthetics, Inc. manufactures and markets biomedical devices for the treatment of defective, diseased, or aging human tissue

Part of Smith & Nephew plc, Smith & Nephew Orthopaedics GmbH is a company headquartered in Tuttlingen, Germany, that manufactures medical devices. Prengel Timo and Wawrzynek Ramona are the current co-CEOs of the firm.

Smith & Nephew PLC designs, manufactures and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is a sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

TianXinFu (Beijing) Medical Appliance Co., Ltd. engages in the medical biomaterial business. It focuses on research and development, production, and sales and service of implantable medical devices. Its medical area covers regenerative medical biomaterials and orthopedics. The biomaterial products include DuraMax, DuraGide and Artificial Nerve, while the orthopedic products are mainly Artificial Hip Replacement and Spine Internal Fixation System. The company was founded on January 18, 2002 and is headquartered in Beijing, China.

Maxigen Biotech, Inc. engages in the research, development, manufacturing, and sales of biomedical materials and beauty care products. It operates through the following segments: Skincare, and Biomedical. The Skincare segment provides face masks, facial cleansers, and body care products. The Biomedical segment offers medical products such as bone graft substitute, ophthalmic viscoelastic, collagen dental graft, collagen wound dressing, and dermal filler injection. The company was founded on December 3, 1998 and is headquartered in Taoyuan, Taiwan.

Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert in 1950 and headquartered in Irvine, CA.

The Visian ICL is an FDA approved implantable lens (known in Europe as an implantable contact lens) that is a doctor recommended vision correction option for people with mild to severe myopia. With Visian ICL, you can enjoy vision that's sharper, clearer, and with greater depth and dimension... in a 15 minute outpatient procedure. Insertion of the lens is a reversible procedure, unlike LASIK, that requires no permanent removal of the corneal tissue. The Visian ICL is patented and manufactured by STAAR Surgical Company.

Anyang Senxi Medical Co., Ltd., established on 2020-09-08, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Instrument sales;Machinery sales;Chemical product sales(No licensed chemical products);Cosmetics Wholesale;Cosmetics Retail;Disinfectant sales(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Import and export;Technology Import and Export;Import and export agency;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Cosmetic production;Disinfectant production(Free of Hazardous Chemicals);Drug retail(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Shangcheng Yimei (Chengdu) Biotechnology Co., Ltd., established on 2018-12-03, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Cosmetics Wholesale;Cosmetics Retail;Healthy food(prepackaged)Sales;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Class II Medical Device Leasing;Specialty Chemicals Sales(Free of Hazardous Chemicals);R&D and application of cell technology;Biomass Energy Technology Services;Import and export;Import and export agency;Manufacture of special equipment for daily chemical industry;software development;internet sales(Except for products that require a license for sale);Non-residential real estate leases(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Cosmetic production;Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Internet Information Service for Medical Devices;Bonded Warehouse Operation;Health food production;Life beauty service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments).

Hangzhou Luyang Technology Co., Ltd., established on 2017-07-24, Business scope includes services:Computer hardware and software,Technology Development of Network Technology,Technical Services,technical consulting,Achievement transfer,computer system integration,Organize cultural and artistic exchange activities planning(Excluding performances and performance intermediaries),marketing planning,Corporate Image Planning,translation service,business management,Exhibition display service,Conference Services,Landscape Design,design,make,acting,Post domestic advertisements(In addition to online advertising),graphic design,make,type,copy,Own Equipment Rental;wholesale,retail:metallic material,decorative material,Daily necessities.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)